Knightsbridge Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.42M Sell
6,747
-3
-0% -$602 0.16% 74
2026
Q2
$1.28M Hold
6,750
– – 0.17% 68
2026
Q1
$1.14M Hold
6,750
– – 0.15% 72
2025
Q4
$1.14M Hold
6,750
– – 0.18% 68
2025
Q3
$974K Sell
6,750
-390
-5% -$53.2K 0.16% 71
2025
Q2
$903K Buy
7,140
+450
+7% +$55.2K 0.2% 65
2025
Q1
$856K Sell
6,690
-1,335
-17% -$181K 0.22% 63
2024
Q4
$1.06M Sell
8,025
-72
-0.9% -$10.1K 0.25% 59
2024
Q3
$1.18M Hold
8,097
– – 0.26% 58
2024
Q2
$1.11M Sell
8,097
-93
-1% -$12.4K 0.28% 58
2024
Q1
$1.11M Hold
8,190
– – 0.31% 57
2023
Q4
$1.11M Sell
8,190
-510
-6% -$62.2K 0.31% 57
2023
Q3
$1.06M Hold
8,700
– – 0.34% 57
2023
Q2
$1.1M Sell
8,700
-8,700
-50% -$1.13M 0.36% 56
2023
Q1
$2.25M Hold
17,400
– – 0.38% 55
2022
Q4
$2.28M Hold
17,400
– – 0.43% 55
2022
Q3
$2.04M Hold
17,400
– – 0.43% 50
2022
Q2
$2.05M Buy
17,400
+7,750
+80% +$920K 0.41% 50
2022
Q1
$1.26M Hold
9,650
– – 0.42% 52
2021
Q4
$1.47M Hold
9,650
– – 0.49% 50
2021
Q3
$1.56M Sell
9,650
-700
-7% -$118K 0.55% 45
2021
Q2
$1.69M Hold
10,350
– – 0.66% 35
2021
Q1
$1.56M Hold
10,350
– – 0.66% 33
2020
Q4
$1.57M Hold
10,350
– – 0.77% 29
2020
Q3
$1.4M Hold
10,350
– – 0.81% 29
2020
Q2
$1.42M Buy
+10,350
New +$1.32M 0.92% 26

Other funds holding IBB

Knightsbridge Asset Management's IBB Position: Q3 2026 in Review

Knightsbridge Asset Management reduced its iShares Biotechnology ETF (IBB) stake by 0.04% in Q3 2026, selling an estimated $602 and leaving 6,747 shares worth $1.42M. The position accounts for 0.16% of the portfolio, ranked #74.

Knightsbridge Asset Management first reported a position in IBB in Q2 2020 and has held it in 26 quarters since. The position peaked at $2.28M in Q4 2022. 1,026 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Knightsbridge Asset Management held 6,747 shares of iShares Biotechnology ETF worth $1.42M as of Q3 2026.
  • Knightsbridge Asset Management sold 3 iShares Biotechnology ETF shares in Q3 2026, an estimated $602.
  • iShares Biotechnology ETF made up 0.16% of Knightsbridge Asset Management's portfolio in Q3 2026, its #74 holding.
  • Knightsbridge Asset Management first reported a position in iShares Biotechnology ETF in Q2 2020 and has held it in 26 quarters since.
  • Knightsbridge Asset Management's iShares Biotechnology ETF position peaked at $2.28M in Q4 2022.
  • 1,026 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Knightsbridge Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.